AbbVie Inc. (LON:0QCV)
London · Delayed Price · Currency is GBP · Price in USD 242.63
+12.74 (5.54%)
At close: Oct 1, 2025
AbbVie Market Cap
AbbVie has a market cap or net worth of 306.63 billion as of October 3, 2025. Its market cap has increased by 18.82% in one year.
Market Cap
306.63B
Enterprise Value
354.24B
Revenue
42.57B
Ranking
n/a
PE Ratio
112.84
Stock Price
242.63
Market Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 34.43B to 306.63B, an increase of 790.57%. That is a compound annual growth rate of 18.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 306.63B | 22.24% |
| Dec 31, 2024 | 250.83B | 16.77% |
| Dec 29, 2023 | 214.80B | -9.41% |
| Dec 30, 2022 | 237.12B | 34.13% |
| Dec 31, 2021 | 176.78B | 27.59% |
| Dec 31, 2020 | 138.56B | 40.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.64B |
| ConvaTec Group | 4.81B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |